Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)
- Citation:
- Clin Cancer Res vol 27 (1) 267-75
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Bristol Myers Squibb (BMS), Genentech, Pfizer, and Sanofi
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233327, UG1CA233373, U10CA180888(SWOG)
- Corr. Author:
- Authors:
- Federico Innocenti Alexander B. Sibley Sushant A. Patil Amy S. Etheridge Chen Jiang Fang-Shu Ou Stefanie D. Howell Sarah J Plummer Graham Casey Monica M. Bertagnolli Howard L. McLeod James T. Auman Charles D. Blanke Yoichi Furukawa Alan P. Venook Michiaki Kubo Heinz-Josef Lenz Joel S. Parker Mark J. Ratain Kouros Owzar
- Networks:
- CA011, CA136, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC007, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: